Podcasts by Alcon
20 Years of Artificial Tears: Insights From a Visionary Behind Systane®
20 years ago, the original Systane® lubricant eye drops revolutionized artificial tears. Since then, the Systane® brand has evolved into multiple products for a variety of patients experiencing dry eye. Learn more from Howard Ketelson PhD, former Head of Dry Eye Care Ideation and Innovation at Alcon – and one of the inventors of the Systane® platform – as he discusses the latest from this innovative brand.
Mobile Access
Listen Now
References:
- Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26:347-353.
- Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-Guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 204;28:55-62.
- Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575-628.
- Benelli U. Systane® lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011;5:783-790.
- Ketelson HA, Davis J, Meadows D. Extensional rheological properties of Systane® Ultra. Poster presented at Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting; May 3-7, 2009; Fort Lauderdale, FL.
- Jerkins G, Greiner JV, Tong L, et al. A comparison of efficacy and safety of two lipid-based lubricant eye drops for the management of evaporative dry eye disease. Clin Ophthalmol. 2020;14:1665-1673.
- Korb D, Blackie C, Meadows D, Christensen M, Tudor M. Evaluation of extended tear stability by two emulsion based artificial tears. Poster presented at 6th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance; September 22-25, 2010; Florence, Italy.
- Kobayashi Y, Okamoto A, Nishinari K. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology. 1994;31:235-244.
- Labetoulle M, Schmickler S, Galarreta D, et al. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study. Clin Ophthalmol. 2018;12:2499-2508.
- Salzillo R, Schiraldi C, Corsuto L, et al. Optimization of hyaluronan-based eye drop formulations. Carbohydr Polym. 2016;153:275-283.
- Rah MJ. A review of hyaluronan and its ophthalmic applications. Optometry. 2011;82:38-43.
- Ogundele A, Ketelson H, Rangarajan R. The effect of a novel hydroxypropyl-guar phospholipid nanoemulsion based artificial tear solution in in vitro and ex vivo corneal epithelium models. Presented at 8th EuCornea Congress; October 6-7, 2017; Lisbon, Portugal.
- Rangarajan R, Ketelson H. Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium. J Ocul Pharmacol Ther. 2019;35:32-37.
- Silverstein S, Yeu E, Tauber J, et al. Symptom relief following a single dose of propylene glycol-hydroxypropyl guar nanoemulsion in patients with dry eye disease: a phase IV, multicenter trial. Clin Ophthalmol. 2020;14:3167.
- Craig JP, Muntz A, Wang MTM, et al. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. Ocul Surf. 2021;20:62-69.
- Rohit A, Willcox M, Stapleton F. Tear lipid layer and contact lens comfort: a review. Eye Contact Lens. 2013;39:247-253.
- Yeu E, Silverstein S, Guillon M, et al. Efficacy and safety of phospholipid nanoemulsion-based ocular lubricant for the management of various subtypes of dry eye disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020; 14:2561-2570.